131 related articles for article (PubMed ID: 1866861)
1. Recombinant alpha interferon in metastatic renal cell carcinoma. A cooperative phase II study.
Bono AV; Reali L; Benvenuti C; Rigatti P; Gibba A; Cosciani-Cunico S; Brausi M; Vicini D; Pavone-Macaluso M; Anselmo G
Urology; 1991 Jul; 38(1):60-3. PubMed ID: 1866861
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.
Kinney P; Triozzi P; Young D; Drago J; Behrens B; Wise H; Rinehart JJ
J Clin Oncol; 1990 May; 8(5):881-5. PubMed ID: 2332772
[TBL] [Abstract][Full Text] [Related]
3. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
[TBL] [Abstract][Full Text] [Related]
4. Long-term interferon treatment in metastatic renal cell carcinoma.
Levens W; Rübben H; Ingenhag W
Eur Urol; 1989; 16(5):378-81. PubMed ID: 2776808
[TBL] [Abstract][Full Text] [Related]
5. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
[TBL] [Abstract][Full Text] [Related]
6. Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group.
Gleave ME; Elhilali M; Fradet Y; Davis I; Venner P; Saad F; Klotz LH; Moore MJ; Paton V; Bajamonde A
N Engl J Med; 1998 Apr; 338(18):1265-71. PubMed ID: 9562580
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients.
Lopez Hänninen E; Kirchner H; Atzpodien J
J Urol; 1996 Jan; 155(1):19-25. PubMed ID: 7490829
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alpha.
Atzpodien J; Körfer A; Palmer PA; Franks CR; Poliwoda H; Kirchner H
Ann Oncol; 1990 Sep; 1(5):377-8. PubMed ID: 2261378
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
Vugrin D; Hood L; Taylor W; Laszlo J
Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
[TBL] [Abstract][Full Text] [Related]
10. Continuous intravenous interleukin-2 infusion and subcutaneous interferon-alpha in metastatic renal cell carcinoma.
Fosså SD; Aune H; Baggerud E; Granerud T; Heilo A; Theodorsen L
Eur J Cancer; 1993; 29A(9):1313-5. PubMed ID: 8343275
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous recombinant interleukin-2 and alpha-interferon in patients with advanced renal cell carcinoma: results of a multicenter Phase II Study.
Atzpodien J; Kirchner H; de Mulder P; Bodenstein H; Oliver T; Palmer PA; Franks CR; Poliwoda H
Cancer Biother; 1993; 8(4):289-300. PubMed ID: 7804370
[TBL] [Abstract][Full Text] [Related]
12. Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma.
Atzpodien J; Lopez Hänninen E; Kirchner H; Bodenstein H; Pfreundschuh M; Rebmann U; Metzner B; Illiger HJ; Jakse G; Niesel T
J Clin Oncol; 1995 Feb; 13(2):497-501. PubMed ID: 7844611
[TBL] [Abstract][Full Text] [Related]
13. [Phase II trial of treatment of metastatic renal adenocarcinoma with recombinant leukocyte interferon (rDNA IFN-alpha 2)].
Dorval T; Palangie T; Garcia-Giralt E; Jouve M; Bretaudeau B; Falcoff F; Coninx P; Schwab D; Pouillart P
Bull Cancer; 1985; 72(5):470-1. PubMed ID: 4074917
[No Abstract] [Full Text] [Related]
14. Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.
Figlin RA; deKernion JB; Mukamel E; Palleroni AV; Itri LM; Sarna GP
J Clin Oncol; 1988 Oct; 6(10):1604-10. PubMed ID: 3049952
[TBL] [Abstract][Full Text] [Related]
15. The use of interferon alpha-C in patients with metastatic renal cell carcinoma arising in a congenital solitary kidney.
Merimsky O; Merimsky E; Chaitchik S
J Surg Oncol; 1990 Dec; 45(4):279-81. PubMed ID: 2250479
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
Rinehart J; Malspeis L; Young D; Neidhart J
Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
[TBL] [Abstract][Full Text] [Related]
17. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
Kempf RA; Grunberg SM; Daniels JR; Skinner DG; Venturi CL; Spiegel R; Neri R; Greiner JM; Rudnick S; Mitchell MS
J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma.
Lümmen G; Goepel M; Möllhoff S; Hinke A; Otto T; Rübben H
J Urol; 1996 Feb; 155(2):455-8. PubMed ID: 8558634
[TBL] [Abstract][Full Text] [Related]
19. A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.
Ernstoff MS; Nair S; Bahnson RR; Miketic LM; Banner B; Gooding W; Day R; Whiteside T; Hakala T; Kirkwood JM
J Clin Oncol; 1990 Oct; 8(10):1637-49. PubMed ID: 2120392
[TBL] [Abstract][Full Text] [Related]
20. Interferon therapy for metastatic renal cell carcinoma.
Swanson DA; Quesada JR
Semin Surg Oncol; 1988; 4(3):174-7. PubMed ID: 3142007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]